Coluracetam CAS: 135463-81-9 Smart Drugs for Brain Improve Belong to Nootropics

• Post Date:

  Sep 30,2017

• Expiry Date:

  Sep 30,2018

• Detailed Description:

  details.:ulalee@yuanchengtech.com
  ,whatsapp: +8618872220744
  Superlist Name:Coluracetam
  Molecular Formula:C19H23N3O3
  Coluracetam CAS No.:135463-81-9
  Coluracetam Purity:99%
  Coluracetam Synonyms:N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
  Coluracetam Molecular Weight:341.40
  Coluracetam Appearance:white crystal powder
  Coluracetam Boiling Point:634.1°C at 760 mmHg °C
  Coluracetam Application:mainly applied to promote intellectual product. /raw material used in Synthesis/ pharmaceutical raw material
  
  Description of Coluracetam
  Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease.
  Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown
  Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.
  
  What is Coluracetam?
  Coluracetam is one of the newer racetam nootropics to hit the market. The idea behind this powerful compound is that it acts as a Choline uptake enhancer. In other words, the purpose of this nootropic is to enhance the effects of Choline on the brain and body.
  This includes the increased production of Acetylcholine, without which it would be impossible move our muscles or even be able to remember simple facts. Not only does coluracetam increase the production of Acetylcholine, but it also speeds up its flow in brain synapses. This product was first registered in 2005 and phase 2A trials were completed back in 2010.
  
  
  Effects :
  After acquiring the trademark from Mitsubishi Tanabe, BrainCells Inc. immediately began testing the effects of Coluracetam. As there weren't enough participants to take part in clinical trials for Coluracetam, most of these tests were conducted on rats instead. From these tests, Coluracetam was shown to markedly improve memory, learning and anxiety.
  

• Company:

  hubei gongchuang ltd.c     [ China ]        

• Contact:

  ulalee

• Tel:

  +86-571-15784251

• Fax:

• Email:

  gcgj11@ycphar.com